Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Nitroglycerin | 12 | 2011 | 329 | 2.040 |
Why?
|
Vasodilator Agents | 15 | 2011 | 973 | 1.470 |
Why?
|
Cardiac Pacing, Artificial | 15 | 2009 | 866 | 1.200 |
Why?
|
Sympathetic Nervous System | 8 | 2012 | 518 | 1.180 |
Why?
|
Endothelium, Vascular | 15 | 2012 | 4431 | 1.090 |
Why?
|
Vasodilation | 11 | 2011 | 962 | 1.080 |
Why?
|
Drug Tolerance | 8 | 2011 | 367 | 1.040 |
Why?
|
Angina Pectoris | 9 | 2009 | 959 | 0.770 |
Why?
|
Nitrates | 6 | 2009 | 263 | 0.750 |
Why?
|
Heart Failure | 26 | 2012 | 11670 | 0.700 |
Why?
|
Brachial Artery | 2 | 2011 | 366 | 0.640 |
Why?
|
Inclusion Bodies, Viral | 5 | 2004 | 45 | 0.570 |
Why?
|
Heart | 27 | 2012 | 4404 | 0.540 |
Why?
|
Reoviridae | 5 | 2004 | 162 | 0.530 |
Why?
|
Ventricular Function, Left | 13 | 2012 | 3879 | 0.530 |
Why?
|
Hemodynamics | 19 | 2012 | 4160 | 0.530 |
Why?
|
Isosorbide Dinitrate | 2 | 2007 | 34 | 0.520 |
Why?
|
Norepinephrine | 5 | 2012 | 897 | 0.520 |
Why?
|
Radionuclide Imaging | 45 | 2021 | 1972 | 0.520 |
Why?
|
Nuclear Medicine | 5 | 2003 | 237 | 0.510 |
Why?
|
Dobutamine | 2 | 2008 | 116 | 0.500 |
Why?
|
Myocardial Reperfusion Injury | 2 | 2010 | 481 | 0.460 |
Why?
|
Ventricular Dysfunction, Left | 7 | 2012 | 2118 | 0.450 |
Why?
|
Adrenergic beta-Agonists | 2 | 2008 | 345 | 0.450 |
Why?
|
Cardiomyopathy, Dilated | 4 | 2009 | 829 | 0.430 |
Why?
|
Ischemic Preconditioning, Myocardial | 3 | 2010 | 69 | 0.410 |
Why?
|
Coronary Disease | 19 | 2011 | 5914 | 0.410 |
Why?
|
Coronary Circulation | 10 | 2012 | 1569 | 0.400 |
Why?
|
Nitric Oxide Synthase | 3 | 2010 | 908 | 0.370 |
Why?
|
omega-N-Methylarginine | 1 | 2010 | 108 | 0.360 |
Why?
|
Pulmonary Embolism | 13 | 2001 | 2567 | 0.360 |
Why?
|
Acetylcholine | 2 | 2010 | 629 | 0.350 |
Why?
|
Folic Acid | 2 | 2010 | 1323 | 0.350 |
Why?
|
Radial Artery | 2 | 2010 | 187 | 0.350 |
Why?
|
Free Radicals | 3 | 2009 | 238 | 0.340 |
Why?
|
Piperazines | 5 | 2007 | 2523 | 0.340 |
Why?
|
Metoprolol | 2 | 2011 | 90 | 0.330 |
Why?
|
Propanolamines | 2 | 2011 | 163 | 0.330 |
Why?
|
Myocardial Ischemia | 8 | 2011 | 2113 | 0.320 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 11 | 2009 | 1068 | 0.320 |
Why?
|
Heptanoic Acids | 1 | 2011 | 344 | 0.320 |
Why?
|
Nitro Compounds | 1 | 2008 | 74 | 0.310 |
Why?
|
Vitamin B Complex | 1 | 2010 | 299 | 0.310 |
Why?
|
Carbazoles | 2 | 2011 | 220 | 0.310 |
Why?
|
Double-Blind Method | 18 | 2011 | 12341 | 0.300 |
Why?
|
Fluorobenzenes | 1 | 2010 | 179 | 0.300 |
Why?
|
Sulfones | 3 | 2007 | 448 | 0.300 |
Why?
|
Organometallic Compounds | 5 | 2021 | 647 | 0.300 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2010 | 321 | 0.300 |
Why?
|
Virus Assembly | 4 | 2004 | 139 | 0.300 |
Why?
|
Forearm | 3 | 2010 | 427 | 0.300 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2010 | 705 | 0.290 |
Why?
|
Cyclooxygenase 2 | 1 | 2010 | 597 | 0.290 |
Why?
|
Heart Rate | 13 | 2011 | 4195 | 0.290 |
Why?
|
Viral Proteins | 6 | 2004 | 1804 | 0.290 |
Why?
|
Regional Blood Flow | 7 | 2010 | 1496 | 0.280 |
Why?
|
Nitroprusside | 3 | 2004 | 272 | 0.280 |
Why?
|
Diuretics | 2 | 2007 | 610 | 0.270 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2007 | 214 | 0.270 |
Why?
|
Blood Pressure | 18 | 2012 | 8481 | 0.260 |
Why?
|
Kidney | 3 | 2008 | 7047 | 0.260 |
Why?
|
Viral Core Proteins | 4 | 2004 | 161 | 0.260 |
Why?
|
Viral Nonstructural Proteins | 3 | 2004 | 227 | 0.260 |
Why?
|
Phlebography | 2 | 2006 | 326 | 0.260 |
Why?
|
Nuclear Medicine Department, Hospital | 3 | 2003 | 13 | 0.250 |
Why?
|
Atrioventricular Node | 1 | 2006 | 180 | 0.250 |
Why?
|
Thallium | 8 | 2003 | 100 | 0.250 |
Why?
|
Hypertension, Pulmonary | 2 | 2012 | 1578 | 0.250 |
Why?
|
Cardiac Output | 8 | 2012 | 831 | 0.240 |
Why?
|
Endothelins | 1 | 2005 | 127 | 0.240 |
Why?
|
Coronary Angiography | 10 | 2011 | 4471 | 0.240 |
Why?
|
Pyrroles | 1 | 2011 | 1125 | 0.230 |
Why?
|
Sulfonamides | 2 | 2014 | 1978 | 0.230 |
Why?
|
Pressoreceptors | 1 | 2004 | 99 | 0.230 |
Why?
|
Nitric Oxide Donors | 1 | 2004 | 125 | 0.230 |
Why?
|
Reflex, Abnormal | 1 | 2004 | 83 | 0.230 |
Why?
|
Tissue Plasminogen Activator | 7 | 1997 | 1164 | 0.230 |
Why?
|
Vasoconstriction | 4 | 2011 | 592 | 0.220 |
Why?
|
Elasticity Imaging Techniques | 1 | 2009 | 392 | 0.220 |
Why?
|
Pentaerythritol Tetranitrate | 1 | 2003 | 2 | 0.220 |
Why?
|
Myocardium | 7 | 2010 | 4725 | 0.220 |
Why?
|
Telecommunications | 1 | 2003 | 80 | 0.220 |
Why?
|
Ventilation-Perfusion Ratio | 2 | 2001 | 117 | 0.220 |
Why?
|
Adrenergic beta-Antagonists | 3 | 2009 | 1241 | 0.220 |
Why?
|
Yttrium Radioisotopes | 1 | 2024 | 107 | 0.210 |
Why?
|
Exercise Tolerance | 2 | 2007 | 836 | 0.210 |
Why?
|
Coronary Artery Disease | 7 | 2012 | 6403 | 0.210 |
Why?
|
Cardiotonic Agents | 2 | 2005 | 539 | 0.210 |
Why?
|
Technetium | 13 | 2003 | 317 | 0.200 |
Why?
|
Thrombolytic Therapy | 7 | 1997 | 2064 | 0.200 |
Why?
|
Diastole | 5 | 2003 | 782 | 0.200 |
Why?
|
Baroreflex | 1 | 2002 | 149 | 0.190 |
Why?
|
Meglumine | 4 | 2006 | 144 | 0.190 |
Why?
|
Hyperaldosteronism | 1 | 2004 | 247 | 0.180 |
Why?
|
Microspheres | 1 | 2024 | 784 | 0.180 |
Why?
|
Humans | 148 | 2024 | 761572 | 0.180 |
Why?
|
Endothelium | 1 | 2003 | 765 | 0.180 |
Why?
|
Computer Communication Networks | 3 | 1998 | 293 | 0.180 |
Why?
|
Internet | 2 | 2003 | 3093 | 0.180 |
Why?
|
Radioisotopes | 9 | 1987 | 499 | 0.180 |
Why?
|
Heart Ventricles | 10 | 2006 | 3807 | 0.180 |
Why?
|
Middle Aged | 74 | 2024 | 220920 | 0.180 |
Why?
|
Echocardiography | 12 | 2009 | 4989 | 0.180 |
Why?
|
Hypertension | 6 | 2010 | 8540 | 0.170 |
Why?
|
Arginine | 2 | 2011 | 934 | 0.170 |
Why?
|
Radiology Information Systems | 2 | 2003 | 529 | 0.170 |
Why?
|
Pyrazoles | 1 | 2010 | 2009 | 0.170 |
Why?
|
Male | 89 | 2024 | 360842 | 0.170 |
Why?
|
Thallium Radioisotopes | 5 | 2002 | 138 | 0.160 |
Why?
|
Exercise Test | 15 | 2007 | 2127 | 0.160 |
Why?
|
Infusions, Intravenous | 5 | 2008 | 2218 | 0.160 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2011 | 3245 | 0.150 |
Why?
|
Enzyme Inhibitors | 4 | 2012 | 3713 | 0.150 |
Why?
|
Microtubules | 3 | 2004 | 1074 | 0.150 |
Why?
|
Lung | 9 | 2003 | 10002 | 0.150 |
Why?
|
Tomography, Emission-Computed | 4 | 2001 | 1122 | 0.150 |
Why?
|
Virion | 3 | 2004 | 422 | 0.150 |
Why?
|
Pyrimidines | 1 | 2010 | 3028 | 0.150 |
Why?
|
Liver Neoplasms | 3 | 2024 | 4319 | 0.140 |
Why?
|
Reference Values | 6 | 2011 | 4920 | 0.140 |
Why?
|
Electrocardiography | 16 | 2007 | 6377 | 0.140 |
Why?
|
Sleep Apnea Syndromes | 4 | 2003 | 975 | 0.140 |
Why?
|
Capsid Proteins | 3 | 2004 | 468 | 0.140 |
Why?
|
Indium Radioisotopes | 2 | 1993 | 113 | 0.130 |
Why?
|
Antioxidants | 1 | 2004 | 1668 | 0.130 |
Why?
|
Fuzzy Logic | 1 | 1995 | 57 | 0.130 |
Why?
|
Telemedicine | 2 | 2003 | 3052 | 0.130 |
Why?
|
Urokinase-Type Plasminogen Activator | 4 | 1997 | 325 | 0.120 |
Why?
|
Neuroendocrine Tumors | 1 | 2021 | 641 | 0.120 |
Why?
|
Adult | 53 | 2012 | 221203 | 0.120 |
Why?
|
Dose-Response Relationship, Drug | 6 | 2008 | 10766 | 0.120 |
Why?
|
Indoles | 2 | 2014 | 1833 | 0.120 |
Why?
|
Aged | 52 | 2024 | 169310 | 0.120 |
Why?
|
Cross-Over Studies | 3 | 2007 | 2079 | 0.120 |
Why?
|
Joints | 2 | 1993 | 322 | 0.120 |
Why?
|
Purines | 3 | 2007 | 607 | 0.120 |
Why?
|
Hemangiopericytoma | 1 | 2014 | 71 | 0.110 |
Why?
|
Physical Exertion | 3 | 2004 | 667 | 0.110 |
Why?
|
Orthoreovirus, Mammalian | 2 | 2004 | 40 | 0.110 |
Why?
|
Renal Circulation | 2 | 2005 | 291 | 0.110 |
Why?
|
Energy Metabolism | 1 | 2005 | 2882 | 0.110 |
Why?
|
Sleep Apnea, Obstructive | 4 | 2009 | 1875 | 0.110 |
Why?
|
Female | 71 | 2024 | 392686 | 0.110 |
Why?
|
Pulmonary Circulation | 4 | 1993 | 737 | 0.110 |
Why?
|
Smoking | 1 | 2010 | 9053 | 0.110 |
Why?
|
Nitric Oxide | 3 | 2012 | 2135 | 0.110 |
Why?
|
Teleradiology | 2 | 2003 | 53 | 0.110 |
Why?
|
Sleep, REM | 1 | 1996 | 595 | 0.100 |
Why?
|
Stroke Volume | 11 | 2011 | 5496 | 0.100 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2003 | 3359 | 0.100 |
Why?
|
Heart Failure, Systolic | 2 | 2011 | 135 | 0.100 |
Why?
|
Synovitis | 1 | 1993 | 217 | 0.100 |
Why?
|
Phospholipases A2, Secretory | 1 | 2012 | 30 | 0.100 |
Why?
|
Radiopharmaceuticals | 5 | 2003 | 2651 | 0.100 |
Why?
|
Heart Diseases | 8 | 2010 | 2781 | 0.100 |
Why?
|
Emergency Medical Services | 1 | 2003 | 1923 | 0.100 |
Why?
|
Pericytes | 1 | 2014 | 293 | 0.100 |
Why?
|
Retinal Drusen | 1 | 2012 | 74 | 0.100 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2024 | 2297 | 0.100 |
Why?
|
Autonomic Nervous System Diseases | 2 | 2010 | 269 | 0.100 |
Why?
|
Adrenergic beta-1 Receptor Antagonists | 1 | 2011 | 30 | 0.090 |
Why?
|
Fluorescein | 1 | 2012 | 175 | 0.090 |
Why?
|
Cardiovascular Diseases | 3 | 2008 | 15501 | 0.090 |
Why?
|
Peroneal Nerve | 1 | 2011 | 76 | 0.090 |
Why?
|
Drug Administration Routes | 1 | 2011 | 150 | 0.090 |
Why?
|
Injections, Intradermal | 1 | 2010 | 116 | 0.090 |
Why?
|
Models, Cardiovascular | 2 | 2010 | 981 | 0.090 |
Why?
|
Nocturnal Myoclonus Syndrome | 1 | 2011 | 51 | 0.090 |
Why?
|
Tetrazoles | 2 | 2007 | 909 | 0.090 |
Why?
|
Hemorheology | 1 | 2011 | 144 | 0.090 |
Why?
|
Administration, Cutaneous | 2 | 2003 | 713 | 0.090 |
Why?
|
Acetates | 1 | 2012 | 321 | 0.090 |
Why?
|
Teaching | 1 | 1998 | 1170 | 0.090 |
Why?
|
Reactive Oxygen Species | 3 | 2009 | 2141 | 0.090 |
Why?
|
Analysis of Variance | 3 | 2010 | 6228 | 0.090 |
Why?
|
Heparin | 3 | 1997 | 1634 | 0.090 |
Why?
|
Oxidative Stress | 3 | 2011 | 3113 | 0.090 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 2010 | 260 | 0.090 |
Why?
|
Pulmonary Wedge Pressure | 3 | 2007 | 273 | 0.090 |
Why?
|
Vasomotor System | 1 | 2010 | 207 | 0.090 |
Why?
|
Periodicity | 1 | 2011 | 348 | 0.080 |
Why?
|
Premedication | 1 | 2010 | 246 | 0.080 |
Why?
|
Spleen | 1 | 1995 | 2295 | 0.080 |
Why?
|
Myocardial Contraction | 7 | 2002 | 1515 | 0.080 |
Why?
|
Diltiazem | 2 | 2004 | 131 | 0.080 |
Why?
|
Sodium Pertechnetate Tc 99m | 2 | 1987 | 54 | 0.080 |
Why?
|
Renal Plasma Flow | 1 | 2008 | 27 | 0.080 |
Why?
|
Contrast Media | 4 | 2006 | 5311 | 0.080 |
Why?
|
Treatment Outcome | 13 | 2024 | 64684 | 0.070 |
Why?
|
Time Factors | 19 | 2011 | 39970 | 0.070 |
Why?
|
Sleep Apnea, Central | 1 | 2009 | 88 | 0.070 |
Why?
|
Fluorodeoxyglucose F18 | 3 | 2001 | 2010 | 0.070 |
Why?
|
Blood Flow Velocity | 2 | 2011 | 1371 | 0.070 |
Why?
|
Parathyroid Neoplasms | 1 | 2009 | 242 | 0.070 |
Why?
|
Meckel Diverticulum | 1 | 1987 | 32 | 0.070 |
Why?
|
Fluconazole | 1 | 2008 | 157 | 0.070 |
Why?
|
Gravitation | 1 | 1987 | 82 | 0.070 |
Why?
|
Amiloride | 1 | 2007 | 116 | 0.070 |
Why?
|
Adolescent | 11 | 2011 | 88324 | 0.070 |
Why?
|
Erythrocytes | 6 | 1987 | 2413 | 0.070 |
Why?
|
Hydrochlorothiazide | 1 | 2007 | 94 | 0.070 |
Why?
|
Thyroid Neoplasms | 2 | 2014 | 2332 | 0.070 |
Why?
|
Observer Variation | 3 | 2012 | 2606 | 0.070 |
Why?
|
Coronary Vessels | 6 | 2012 | 3096 | 0.070 |
Why?
|
Patients | 1 | 1993 | 907 | 0.070 |
Why?
|
Drug Administration Schedule | 2 | 2007 | 4853 | 0.070 |
Why?
|
Microscopy, Fluorescence | 2 | 2004 | 2645 | 0.070 |
Why?
|
Blood Circulation | 1 | 2007 | 248 | 0.070 |
Why?
|
Microvessels | 1 | 2011 | 577 | 0.070 |
Why?
|
Movement | 1 | 1993 | 1479 | 0.070 |
Why?
|
Radiography | 6 | 2008 | 6965 | 0.060 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2010 | 513 | 0.060 |
Why?
|
Cardiac Output, Low | 1 | 2006 | 191 | 0.060 |
Why?
|
Fluorescent Dyes | 2 | 2012 | 1903 | 0.060 |
Why?
|
Autonomic Nervous System | 3 | 2003 | 703 | 0.060 |
Why?
|
Liver | 3 | 2002 | 7529 | 0.060 |
Why?
|
Ventricular Function, Right | 2 | 2003 | 617 | 0.060 |
Why?
|
Administration, Oral | 3 | 2003 | 4021 | 0.060 |
Why?
|
Thymus Hyperplasia | 1 | 2005 | 32 | 0.060 |
Why?
|
Orthoreovirus | 1 | 2004 | 22 | 0.060 |
Why?
|
Streptokinase | 1 | 1985 | 186 | 0.060 |
Why?
|
Myristic Acids | 1 | 2004 | 49 | 0.060 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2012 | 1725 | 0.060 |
Why?
|
Creatinine | 1 | 2010 | 1899 | 0.060 |
Why?
|
Sensitivity and Specificity | 7 | 2011 | 14666 | 0.060 |
Why?
|
Ontario | 3 | 2011 | 398 | 0.060 |
Why?
|
Physical Endurance | 1 | 2007 | 366 | 0.060 |
Why?
|
Pyridines | 2 | 2007 | 2875 | 0.060 |
Why?
|
Acute Disease | 6 | 2007 | 7237 | 0.060 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2014 | 2057 | 0.060 |
Why?
|
Calcium Channel Blockers | 2 | 2007 | 694 | 0.060 |
Why?
|
Lactates | 1 | 2005 | 405 | 0.060 |
Why?
|
Glyburide | 1 | 2005 | 116 | 0.060 |
Why?
|
Furosemide | 1 | 2005 | 170 | 0.060 |
Why?
|
Angiogenesis Inhibitors | 1 | 2014 | 2047 | 0.060 |
Why?
|
Echocardiography, Doppler | 3 | 2006 | 897 | 0.060 |
Why?
|
Macular Degeneration | 1 | 2012 | 1007 | 0.060 |
Why?
|
Nucleoside-Triphosphatase | 1 | 2003 | 19 | 0.060 |
Why?
|
Renal Veins | 1 | 2004 | 102 | 0.060 |
Why?
|
Jugular Veins | 1 | 2005 | 210 | 0.060 |
Why?
|
Acid Anhydride Hydrolases | 1 | 2003 | 67 | 0.060 |
Why?
|
Metabolic Clearance Rate | 1 | 2004 | 361 | 0.060 |
Why?
|
Cholesterol, HDL | 1 | 2010 | 1814 | 0.060 |
Why?
|
Coronary Artery Bypass | 2 | 2003 | 2188 | 0.060 |
Why?
|
Amlodipine | 1 | 2004 | 84 | 0.060 |
Why?
|
Atenolol | 1 | 2004 | 99 | 0.060 |
Why?
|
Chest Pain | 1 | 2011 | 1091 | 0.060 |
Why?
|
Body Water | 1 | 1985 | 340 | 0.060 |
Why?
|
Ascorbic Acid | 1 | 2007 | 655 | 0.060 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2005 | 393 | 0.050 |
Why?
|
Plasma Volume | 1 | 2002 | 31 | 0.050 |
Why?
|
Drug Therapy, Combination | 3 | 2011 | 6312 | 0.050 |
Why?
|
Peroxynitrous Acid | 1 | 2002 | 40 | 0.050 |
Why?
|
Oxygen | 2 | 2010 | 4227 | 0.050 |
Why?
|
Disorders of Excessive Somnolence | 1 | 2006 | 277 | 0.050 |
Why?
|
Biotransformation | 1 | 2002 | 166 | 0.050 |
Why?
|
Drug Interactions | 1 | 2007 | 1416 | 0.050 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2006 | 494 | 0.050 |
Why?
|
Computers | 7 | 1983 | 593 | 0.050 |
Why?
|
Prodrugs | 1 | 2004 | 261 | 0.050 |
Why?
|
Clonidine | 1 | 2003 | 169 | 0.050 |
Why?
|
Withholding Treatment | 1 | 2006 | 617 | 0.050 |
Why?
|
Parasympathetic Nervous System | 1 | 2002 | 142 | 0.050 |
Why?
|
Ventricular Dysfunction, Right | 2 | 2005 | 628 | 0.050 |
Why?
|
Ventricular Pressure | 1 | 2003 | 210 | 0.050 |
Why?
|
Microscopy, Immunoelectron | 1 | 2002 | 317 | 0.050 |
Why?
|
Potassium Channels | 1 | 2005 | 537 | 0.050 |
Why?
|
Cell Line | 4 | 2004 | 15601 | 0.050 |
Why?
|
Continuous Positive Airway Pressure | 1 | 2007 | 575 | 0.050 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2010 | 1723 | 0.050 |
Why?
|
Cricetinae | 2 | 2002 | 2423 | 0.050 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2006 | 452 | 0.050 |
Why?
|
Systems Integration | 1 | 2003 | 426 | 0.050 |
Why?
|
Gallium Radioisotopes | 2 | 2021 | 195 | 0.050 |
Why?
|
Superoxides | 1 | 2002 | 387 | 0.050 |
Why?
|
Aged, 80 and over | 14 | 2012 | 58986 | 0.050 |
Why?
|
Specialty Boards | 1 | 2003 | 235 | 0.050 |
Why?
|
Erectile Dysfunction | 1 | 2005 | 444 | 0.050 |
Why?
|
Hospital Departments | 3 | 1990 | 134 | 0.050 |
Why?
|
Cholesterol, LDL | 1 | 2010 | 2382 | 0.050 |
Why?
|
Remote Consultation | 1 | 2003 | 237 | 0.050 |
Why?
|
Polysomnography | 4 | 2011 | 1848 | 0.050 |
Why?
|
Placebo Effect | 1 | 2005 | 518 | 0.050 |
Why?
|
Arthritis, Rheumatoid | 2 | 1993 | 3763 | 0.040 |
Why?
|
Saphenous Vein | 1 | 2003 | 516 | 0.040 |
Why?
|
Retrospective Studies | 10 | 2024 | 80646 | 0.040 |
Why?
|
Gadolinium DTPA | 2 | 2002 | 823 | 0.040 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2006 | 851 | 0.040 |
Why?
|
Liver Diseases | 2 | 2002 | 1298 | 0.040 |
Why?
|
Ventricular Function | 3 | 2011 | 406 | 0.040 |
Why?
|
Myocardial Stunning | 1 | 2000 | 66 | 0.040 |
Why?
|
Vascular Patency | 1 | 2003 | 911 | 0.040 |
Why?
|
Vascular Resistance | 4 | 2011 | 930 | 0.040 |
Why?
|
Technetium Tc 99m Medronate | 1 | 2000 | 131 | 0.040 |
Why?
|
Device Removal | 1 | 2005 | 630 | 0.040 |
Why?
|
Transfection | 3 | 2003 | 5774 | 0.040 |
Why?
|
Animals | 17 | 2009 | 168467 | 0.040 |
Why?
|
Chronic Disease | 4 | 2007 | 9319 | 0.040 |
Why?
|
Selection Bias | 1 | 2002 | 359 | 0.040 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2002 | 592 | 0.040 |
Why?
|
Body Mass Index | 5 | 2010 | 12954 | 0.040 |
Why?
|
Posture | 2 | 2003 | 957 | 0.040 |
Why?
|
Muscles | 1 | 1985 | 1576 | 0.040 |
Why?
|
Oxygen Consumption | 2 | 2005 | 1866 | 0.040 |
Why?
|
Ubiquitin | 1 | 2004 | 839 | 0.040 |
Why?
|
Glomerular Filtration Rate | 1 | 2008 | 2177 | 0.040 |
Why?
|
Sex Factors | 2 | 2010 | 10553 | 0.040 |
Why?
|
Data Collection | 1 | 1989 | 3322 | 0.040 |
Why?
|
Software | 4 | 2002 | 4434 | 0.040 |
Why?
|
Technetium Tc 99m Aggregated Albumin | 2 | 1990 | 66 | 0.040 |
Why?
|
Protein Conformation | 2 | 2004 | 3968 | 0.040 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2003 | 732 | 0.040 |
Why?
|
Myocardial Infarction | 6 | 2009 | 11461 | 0.040 |
Why?
|
Vascular Neoplasms | 1 | 2000 | 166 | 0.040 |
Why?
|
Reference Books | 1 | 1998 | 2 | 0.040 |
Why?
|
Thromboembolism | 1 | 2005 | 995 | 0.040 |
Why?
|
Veins | 1 | 2003 | 768 | 0.040 |
Why?
|
CD-ROM | 1 | 1998 | 24 | 0.040 |
Why?
|
Ultrasonography | 3 | 2008 | 5972 | 0.040 |
Why?
|
Likelihood Functions | 1 | 2001 | 992 | 0.040 |
Why?
|
Oxidation-Reduction | 1 | 2004 | 2231 | 0.040 |
Why?
|
Cause of Death | 2 | 2007 | 3683 | 0.040 |
Why?
|
Hypotension | 2 | 1995 | 879 | 0.040 |
Why?
|
Recombinant Proteins | 4 | 2003 | 6534 | 0.040 |
Why?
|
Arteries | 1 | 2003 | 1123 | 0.040 |
Why?
|
Microcomputers | 1 | 1998 | 141 | 0.040 |
Why?
|
Cardiovascular Agents | 1 | 2004 | 840 | 0.040 |
Why?
|
Gadolinium | 1 | 2002 | 960 | 0.040 |
Why?
|
Blood Vessels | 1 | 2002 | 1113 | 0.030 |
Why?
|
Fibrinolytic Agents | 3 | 1997 | 2084 | 0.030 |
Why?
|
Subtraction Technique | 1 | 1980 | 512 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 2 | 2011 | 20571 | 0.030 |
Why?
|
Ventricular Remodeling | 1 | 2004 | 1267 | 0.030 |
Why?
|
Prospective Studies | 11 | 2012 | 54426 | 0.030 |
Why?
|
Leiomyosarcoma | 1 | 2000 | 422 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2005 | 9002 | 0.030 |
Why?
|
Prognosis | 6 | 2009 | 29629 | 0.030 |
Why?
|
Atrial Fibrillation | 2 | 2005 | 5127 | 0.030 |
Why?
|
Kidney Cortex | 1 | 1976 | 169 | 0.030 |
Why?
|
Muscle, Skeletal | 1 | 2011 | 4948 | 0.030 |
Why?
|
Pulmonary Artery | 3 | 2000 | 1927 | 0.030 |
Why?
|
Defibrillators, Implantable | 1 | 2005 | 1490 | 0.030 |
Why?
|
Educational Technology | 1 | 1995 | 59 | 0.030 |
Why?
|
ROC Curve | 3 | 2011 | 3579 | 0.030 |
Why?
|
Stem Cells | 1 | 2008 | 3523 | 0.030 |
Why?
|
Systole | 3 | 2006 | 936 | 0.030 |
Why?
|
Iridium | 2 | 1986 | 30 | 0.030 |
Why?
|
Young Adult | 3 | 2011 | 59255 | 0.030 |
Why?
|
RNA, Viral | 1 | 2003 | 2846 | 0.030 |
Why?
|
RNA-Binding Proteins | 1 | 2004 | 1897 | 0.030 |
Why?
|
History, 20th Century | 1 | 2003 | 2767 | 0.030 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2002 | 1050 | 0.030 |
Why?
|
Regression Analysis | 2 | 2003 | 6344 | 0.030 |
Why?
|
Genotype | 2 | 2014 | 12990 | 0.030 |
Why?
|
Research Design | 2 | 2007 | 6180 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 4 | 2021 | 36429 | 0.030 |
Why?
|
Severity of Illness Index | 5 | 2007 | 15843 | 0.030 |
Why?
|
Tachycardia | 5 | 1991 | 600 | 0.030 |
Why?
|
Acetanilides | 2 | 2004 | 169 | 0.030 |
Why?
|
Valine | 1 | 2014 | 408 | 0.030 |
Why?
|
Probability | 2 | 2006 | 2477 | 0.030 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2002 | 1310 | 0.030 |
Why?
|
Pentetic Acid | 1 | 1992 | 209 | 0.030 |
Why?
|
Keto Acids | 1 | 2012 | 35 | 0.030 |
Why?
|
Peptides | 1 | 2004 | 4358 | 0.030 |
Why?
|
Syncope | 1 | 1995 | 427 | 0.020 |
Why?
|
Positive-Pressure Respiration | 1 | 1996 | 639 | 0.020 |
Why?
|
Diabetes Mellitus | 1 | 2010 | 5841 | 0.020 |
Why?
|
Patient Selection | 2 | 2001 | 4244 | 0.020 |
Why?
|
Ventriculography, First-Pass | 1 | 1991 | 20 | 0.020 |
Why?
|
Mathematics | 2 | 1983 | 707 | 0.020 |
Why?
|
Dogs | 5 | 1991 | 3839 | 0.020 |
Why?
|
Constriction | 1 | 2011 | 168 | 0.020 |
Why?
|
Calcinosis | 1 | 2000 | 1469 | 0.020 |
Why?
|
Mutation | 2 | 2014 | 30054 | 0.020 |
Why?
|
Sex Distribution | 2 | 2007 | 2281 | 0.020 |
Why?
|
Heart Septal Defects | 1 | 1992 | 190 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2002 | 4740 | 0.020 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 1994 | 477 | 0.020 |
Why?
|
Analog-Digital Conversion | 1 | 1990 | 23 | 0.020 |
Why?
|
Mice | 5 | 2004 | 81533 | 0.020 |
Why?
|
Rheology | 1 | 2012 | 347 | 0.020 |
Why?
|
Age Distribution | 2 | 2007 | 2880 | 0.020 |
Why?
|
Diagnosis, Differential | 5 | 2011 | 12975 | 0.020 |
Why?
|
Indium | 1 | 1990 | 47 | 0.020 |
Why?
|
Clinical Trials as Topic | 2 | 2004 | 8002 | 0.020 |
Why?
|
Hyperhomocysteinemia | 1 | 2011 | 118 | 0.020 |
Why?
|
Lung Diseases | 1 | 2000 | 1909 | 0.020 |
Why?
|
Supination | 1 | 1990 | 70 | 0.020 |
Why?
|
Eating | 2 | 1995 | 1539 | 0.020 |
Why?
|
Bone and Bones | 1 | 2000 | 2568 | 0.020 |
Why?
|
Transposition of Great Vessels | 1 | 1994 | 581 | 0.020 |
Why?
|
Case-Control Studies | 5 | 2007 | 22176 | 0.020 |
Why?
|
Molecular Sequence Data | 1 | 2002 | 17635 | 0.020 |
Why?
|
Cardiac Volume | 1 | 1990 | 197 | 0.020 |
Why?
|
Cerebral Hemorrhage | 2 | 1997 | 2656 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2002 | 3600 | 0.020 |
Why?
|
Models, Biological | 2 | 2002 | 9469 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2014 | 1176 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2003 | 12794 | 0.020 |
Why?
|
Hemorrhage | 2 | 1997 | 3424 | 0.020 |
Why?
|
Technetium Tc 99m Sestamibi | 2 | 2002 | 174 | 0.020 |
Why?
|
Survival Analysis | 3 | 2007 | 10090 | 0.020 |
Why?
|
Hyperparathyroidism | 1 | 2009 | 337 | 0.020 |
Why?
|
Phenotype | 2 | 2004 | 16592 | 0.020 |
Why?
|
Airway Obstruction | 1 | 1992 | 661 | 0.020 |
Why?
|
Prevalence | 3 | 2011 | 15732 | 0.020 |
Why?
|
Clinical Competence | 1 | 2003 | 4793 | 0.020 |
Why?
|
Platelet Activation | 1 | 2011 | 645 | 0.020 |
Why?
|
Computer Systems | 1 | 1989 | 470 | 0.020 |
Why?
|
Plasminogen Activators | 2 | 1997 | 199 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2014 | 2192 | 0.020 |
Why?
|
Dyspnea | 2 | 2007 | 1347 | 0.020 |
Why?
|
Hypotension, Orthostatic | 1 | 1990 | 258 | 0.020 |
Why?
|
Area Under Curve | 1 | 2011 | 1638 | 0.020 |
Why?
|
Nifedipine | 1 | 2007 | 221 | 0.020 |
Why?
|
Wisconsin | 1 | 2006 | 122 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2004 | 9610 | 0.020 |
Why?
|
Pulse | 1 | 1986 | 217 | 0.020 |
Why?
|
Fluorescein Angiography | 1 | 2012 | 1059 | 0.020 |
Why?
|
DNA, Viral | 2 | 2003 | 2202 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2014 | 3603 | 0.020 |
Why?
|
Linear Models | 2 | 2011 | 5872 | 0.020 |
Why?
|
Papillary Muscles | 1 | 1986 | 192 | 0.020 |
Why?
|
Virus Replication | 2 | 2004 | 2435 | 0.020 |
Why?
|
Gastrointestinal Hemorrhage | 2 | 1983 | 1116 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2021 | 6485 | 0.020 |
Why?
|
Kidney Diseases | 1 | 1976 | 2091 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2009 | 10212 | 0.020 |
Why?
|
Spironolactone | 1 | 2009 | 412 | 0.020 |
Why?
|
Antipyrine | 1 | 1985 | 40 | 0.020 |
Why?
|
Phosphocreatine | 1 | 1985 | 261 | 0.020 |
Why?
|
Injections, Intra-Arterial | 1 | 1985 | 182 | 0.020 |
Why?
|
Reassortant Viruses | 1 | 2004 | 36 | 0.020 |
Why?
|
Nocodazole | 1 | 2004 | 95 | 0.020 |
Why?
|
Lepidoptera | 1 | 2004 | 24 | 0.010 |
Why?
|
Spodoptera | 1 | 2004 | 141 | 0.010 |
Why?
|
Computer Simulation | 1 | 1998 | 6241 | 0.010 |
Why?
|
Baculoviridae | 1 | 2004 | 115 | 0.010 |
Why?
|
Syndrome | 1 | 2011 | 3267 | 0.010 |
Why?
|
Follow-Up Studies | 6 | 2005 | 39107 | 0.010 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2011 | 1516 | 0.010 |
Why?
|
Phosphines | 1 | 2003 | 18 | 0.010 |
Why?
|
Radionuclide Ventriculography | 2 | 1994 | 40 | 0.010 |
Why?
|
Telephone | 2 | 1989 | 627 | 0.010 |
Why?
|
Incidence | 3 | 2007 | 21355 | 0.010 |
Why?
|
Meta-Analysis as Topic | 1 | 2009 | 1380 | 0.010 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2011 | 1496 | 0.010 |
Why?
|
Captopril | 1 | 2004 | 265 | 0.010 |
Why?
|
Predictive Value of Tests | 2 | 2011 | 15266 | 0.010 |
Why?
|
Electrophysiology | 1 | 2006 | 1262 | 0.010 |
Why?
|
Aorta | 1 | 1991 | 2041 | 0.010 |
Why?
|
Genes, Viral | 1 | 2004 | 649 | 0.010 |
Why?
|
Tomography, Spiral Computed | 1 | 2005 | 273 | 0.010 |
Why?
|
Child, Preschool | 4 | 2006 | 42230 | 0.010 |
Why?
|
Angiocardiography | 4 | 1979 | 149 | 0.010 |
Why?
|
Nucleotides | 1 | 1985 | 454 | 0.010 |
Why?
|
Precipitin Tests | 1 | 2003 | 813 | 0.010 |
Why?
|
Hypertrophy, Right Ventricular | 1 | 2003 | 108 | 0.010 |
Why?
|
Aging | 2 | 1993 | 8711 | 0.010 |
Why?
|
Brain Neoplasms | 2 | 2002 | 9031 | 0.010 |
Why?
|
Viral Regulatory and Accessory Proteins | 1 | 2003 | 153 | 0.010 |
Why?
|
Jejunal Diseases | 1 | 1983 | 46 | 0.010 |
Why?
|
Age Factors | 3 | 2009 | 18398 | 0.010 |
Why?
|
Equipment Failure | 1 | 2005 | 578 | 0.010 |
Why?
|
Cell Membrane Permeability | 1 | 2004 | 575 | 0.010 |
Why?
|
Hydrolysis | 1 | 2003 | 664 | 0.010 |
Why?
|
Licensure | 1 | 2003 | 128 | 0.010 |
Why?
|
Heart Septum | 1 | 1983 | 301 | 0.010 |
Why?
|
Angiography | 4 | 1997 | 1595 | 0.010 |
Why?
|
Visual Acuity | 1 | 2012 | 2672 | 0.010 |
Why?
|
Base Sequence | 2 | 2003 | 12441 | 0.010 |
Why?
|
Neoplasms | 2 | 2003 | 22173 | 0.010 |
Why?
|
Aortic Aneurysm | 1 | 1986 | 648 | 0.010 |
Why?
|
Comorbidity | 2 | 2007 | 10508 | 0.010 |
Why?
|
Radiology | 1 | 1995 | 2113 | 0.010 |
Why?
|
Inflammation | 2 | 2012 | 10773 | 0.010 |
Why?
|
Safety | 1 | 2006 | 1150 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2007 | 2850 | 0.010 |
Why?
|
Homeostasis | 2 | 2009 | 3323 | 0.010 |
Why?
|
Iodine Radioisotopes | 1 | 1985 | 1031 | 0.010 |
Why?
|
Jejunum | 1 | 1983 | 472 | 0.010 |
Why?
|
Protein Folding | 1 | 2004 | 870 | 0.010 |
Why?
|
Electrodes, Implanted | 1 | 2005 | 840 | 0.010 |
Why?
|
Chelating Agents | 1 | 2002 | 387 | 0.010 |
Why?
|
Tissue and Organ Harvesting | 1 | 2003 | 373 | 0.010 |
Why?
|
Graft Occlusion, Vascular | 1 | 2003 | 537 | 0.010 |
Why?
|
Multienzyme Complexes | 1 | 2003 | 666 | 0.010 |
Why?
|
Anastomosis, Surgical | 1 | 2003 | 983 | 0.010 |
Why?
|
Amino Acid Substitution | 1 | 2004 | 1739 | 0.010 |
Why?
|
Professional Competence | 1 | 2003 | 431 | 0.010 |
Why?
|
Thymus Gland | 1 | 2005 | 1243 | 0.010 |
Why?
|
Respiration | 1 | 1986 | 1657 | 0.010 |
Why?
|
Heroin | 1 | 2000 | 119 | 0.010 |
Why?
|
Pregnancy Outcome | 1 | 2010 | 2922 | 0.010 |
Why?
|
Organ Size | 1 | 1985 | 2254 | 0.010 |
Why?
|
CHO Cells | 1 | 2002 | 1387 | 0.010 |
Why?
|
Heroin Dependence | 1 | 2000 | 172 | 0.010 |
Why?
|
Methods | 2 | 1987 | 1067 | 0.010 |
Why?
|
Radiology Department, Hospital | 1 | 1983 | 406 | 0.010 |
Why?
|
Heart Defects, Congenital | 1 | 1976 | 4671 | 0.010 |
Why?
|
Signal Transduction | 1 | 2002 | 23447 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 2003 | 2468 | 0.010 |
Why?
|
Kidney Neoplasms | 1 | 1976 | 4251 | 0.010 |
Why?
|
Adenosine Triphosphate | 2 | 2003 | 1989 | 0.010 |
Why?
|
Single-Blind Method | 1 | 2003 | 1574 | 0.010 |
Why?
|
Adaptation, Physiological | 1 | 2006 | 1301 | 0.010 |
Why?
|
Rhabdomyolysis | 1 | 2000 | 152 | 0.010 |
Why?
|
Sleep | 2 | 2006 | 4768 | 0.010 |
Why?
|
Suture Techniques | 1 | 2003 | 769 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2014 | 10448 | 0.010 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2003 | 740 | 0.010 |
Why?
|
Narcotics | 1 | 2000 | 336 | 0.010 |
Why?
|
Stress, Physiological | 1 | 1986 | 1403 | 0.010 |
Why?
|
Death, Sudden, Cardiac | 1 | 2006 | 1555 | 0.010 |
Why?
|
False Positive Reactions | 2 | 1994 | 957 | 0.010 |
Why?
|
Child | 4 | 2006 | 80156 | 0.010 |
Why?
|
Pyridones | 1 | 1983 | 809 | 0.010 |
Why?
|
Sequence Deletion | 1 | 2002 | 1494 | 0.010 |
Why?
|
Temperature | 1 | 2004 | 2226 | 0.010 |
Why?
|
Melena | 1 | 1997 | 32 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2014 | 16986 | 0.010 |
Why?
|
Echo-Planar Imaging | 1 | 2002 | 663 | 0.010 |
Why?
|
Corpus Callosum | 1 | 2002 | 751 | 0.010 |
Why?
|
Microtubule-Associated Proteins | 1 | 2002 | 1076 | 0.010 |
Why?
|
Mitral Valve Insufficiency | 1 | 1986 | 1400 | 0.010 |
Why?
|
Thorax | 2 | 1994 | 555 | 0.010 |
Why?
|
Partial Thromboplastin Time | 1 | 1997 | 204 | 0.010 |
Why?
|
Rest | 1 | 2002 | 918 | 0.010 |
Why?
|
Hemiplegia | 1 | 1997 | 136 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2003 | 2358 | 0.010 |
Why?
|
Risk Factors | 4 | 2011 | 74213 | 0.010 |
Why?
|
Hemangioma | 1 | 1981 | 727 | 0.010 |
Why?
|
Logistic Models | 1 | 2011 | 13255 | 0.010 |
Why?
|
Cineangiography | 2 | 1987 | 108 | 0.010 |
Why?
|
Hematuria | 1 | 1997 | 233 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2014 | 9280 | 0.010 |
Why?
|
Hematocrit | 1 | 1997 | 623 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2003 | 2915 | 0.010 |
Why?
|
Information Systems | 1 | 1997 | 396 | 0.010 |
Why?
|
Risk Assessment | 2 | 2007 | 23996 | 0.010 |
Why?
|
Binding Sites | 1 | 2003 | 6056 | 0.010 |
Why?
|
Splanchnic Circulation | 1 | 1995 | 119 | 0.010 |
Why?
|
Antihypertensive Agents | 1 | 2004 | 2024 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2002 | 3733 | 0.010 |
Why?
|
Swine | 1 | 2003 | 5915 | 0.010 |
Why?
|
Pneumonectomy | 1 | 2000 | 1119 | 0.010 |
Why?
|
Consensus | 1 | 2003 | 3123 | 0.010 |
Why?
|
Heart Function Tests | 1 | 1973 | 318 | 0.010 |
Why?
|
Graft Survival | 1 | 2003 | 3820 | 0.010 |
Why?
|
Blood Volume Determination | 1 | 1972 | 41 | 0.010 |
Why?
|
Serum Albumin | 2 | 1973 | 672 | 0.010 |
Why?
|
Computer-Assisted Instruction | 1 | 1995 | 362 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2007 | 12463 | 0.010 |
Why?
|
Isoproterenol | 1 | 1972 | 395 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 1997 | 1702 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2003 | 3466 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2003 | 13446 | 0.010 |
Why?
|
Catheterization | 1 | 1997 | 1428 | 0.010 |
Why?
|
Drinking | 1 | 1993 | 198 | 0.010 |
Why?
|
Recurrence | 2 | 1997 | 8466 | 0.010 |
Why?
|
Confidence Intervals | 1 | 1997 | 2927 | 0.010 |
Why?
|
Consciousness | 1 | 1997 | 601 | 0.010 |
Why?
|
Electrocardiography, Ambulatory | 1 | 1994 | 578 | 0.010 |
Why?
|
Propranolol | 1 | 1972 | 489 | 0.010 |
Why?
|
Clinical Protocols | 1 | 1996 | 1440 | 0.010 |
Why?
|
Graft Rejection | 1 | 2003 | 4446 | 0.010 |
Why?
|
Visual Fields | 1 | 1997 | 1062 | 0.010 |
Why?
|
Vision Disorders | 1 | 1997 | 1088 | 0.010 |
Why?
|
Patient Admission | 1 | 1997 | 1367 | 0.010 |
Why?
|
Random Allocation | 1 | 1994 | 2395 | 0.010 |
Why?
|
Cerebrovascular Disorders | 1 | 1976 | 1474 | 0.010 |
Why?
|
Infant | 2 | 2006 | 36192 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2004 | 18965 | 0.000 |
Why?
|
Pregnancy | 1 | 2010 | 29876 | 0.000 |
Why?
|
Biopsy | 1 | 2000 | 6766 | 0.000 |
Why?
|
Evaluation Studies as Topic | 2 | 1982 | 1624 | 0.000 |
Why?
|
Publishing | 1 | 1995 | 833 | 0.000 |
Why?
|
Heart Atria | 2 | 1984 | 1345 | 0.000 |
Why?
|
Biometry | 1 | 1991 | 563 | 0.000 |
Why?
|
Acute Kidney Injury | 1 | 2000 | 1924 | 0.000 |
Why?
|
Cohort Studies | 1 | 2011 | 41493 | 0.000 |
Why?
|
Hospital Information Systems | 1 | 1990 | 394 | 0.000 |
Why?
|
Chi-Square Distribution | 1 | 1994 | 3416 | 0.000 |
Why?
|
Asthma | 1 | 1986 | 6234 | 0.000 |
Why?
|
Glioblastoma | 1 | 2002 | 3482 | 0.000 |
Why?
|
Hemothorax | 1 | 1986 | 57 | 0.000 |
Why?
|
Radionuclide Generators | 1 | 1986 | 12 | 0.000 |
Why?
|
Synovial Membrane | 1 | 1990 | 532 | 0.000 |
Why?
|
Drug Combinations | 1 | 1992 | 2048 | 0.000 |
Why?
|
Fibrin | 1 | 1988 | 507 | 0.000 |
Why?
|
Nucleosides | 1 | 1985 | 131 | 0.000 |
Why?
|
Fibrinogen | 1 | 1988 | 888 | 0.000 |
Why?
|
Cardiomegaly | 1 | 1987 | 590 | 0.000 |
Why?
|
Reproducibility of Results | 1 | 2003 | 20099 | 0.000 |
Why?
|
Monitoring, Physiologic | 1 | 1972 | 1779 | 0.000 |
Why?
|
Postoperative Complications | 1 | 1986 | 15633 | 0.000 |
Why?
|
Multivariate Analysis | 1 | 1997 | 12059 | 0.000 |
Why?
|
Vital Capacity | 1 | 1986 | 971 | 0.000 |
Why?
|
Hospital Mortality | 1 | 1997 | 5293 | 0.000 |
Why?
|
Milrinone | 1 | 1983 | 86 | 0.000 |
Why?
|
Cost-Benefit Analysis | 2 | 1989 | 5492 | 0.000 |
Why?
|
Phenylephrine | 1 | 1984 | 293 | 0.000 |
Why?
|
Pressure | 1 | 1986 | 1154 | 0.000 |
Why?
|
Survival Rate | 1 | 1997 | 12725 | 0.000 |
Why?
|
Technology, Radiologic | 1 | 1983 | 160 | 0.000 |
Why?
|
Splenic Rupture | 1 | 1982 | 26 | 0.000 |
Why?
|
Pubic Bone | 1 | 1982 | 31 | 0.000 |
Why?
|
Electricity | 1 | 1983 | 181 | 0.000 |
Why?
|
Drug Evaluation | 1 | 1983 | 641 | 0.000 |
Why?
|
Osteoarthritis | 1 | 1990 | 1063 | 0.000 |
Why?
|
Cranial Fossa, Posterior | 1 | 1982 | 135 | 0.000 |
Why?
|
Technetium Tc 99m Sulfur Colloid | 1 | 1981 | 63 | 0.000 |
Why?
|
Cross-Sectional Studies | 1 | 2003 | 26127 | 0.000 |
Why?
|
Accidental Falls | 1 | 1990 | 1068 | 0.000 |
Why?
|
Anticoagulants | 1 | 1997 | 4812 | 0.000 |
Why?
|
Injections, Intravenous | 1 | 1983 | 1379 | 0.000 |
Why?
|
Data Display | 1 | 1981 | 175 | 0.000 |
Why?
|
Sulfur | 1 | 1981 | 162 | 0.000 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1985 | 2496 | 0.000 |
Why?
|
Diverticulitis, Colonic | 1 | 1982 | 138 | 0.000 |
Why?
|
Gallbladder | 1 | 1982 | 308 | 0.000 |
Why?
|
Sacrum | 1 | 1982 | 276 | 0.000 |
Why?
|
Esophagus | 1 | 1986 | 1033 | 0.000 |
Why?
|
Photography | 1 | 1983 | 532 | 0.000 |
Why?
|
Aorta, Thoracic | 1 | 1986 | 1096 | 0.000 |
Why?
|
Heart Septal Defects, Atrial | 1 | 1983 | 451 | 0.000 |
Why?
|
Stress, Mechanical | 1 | 1984 | 1674 | 0.000 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 1983 | 710 | 0.000 |
Why?
|
Electroencephalography | 1 | 1992 | 6237 | 0.000 |
Why?
|
Nitrogen Radioisotopes | 1 | 1976 | 41 | 0.000 |
Why?
|
Oxygen Radioisotopes | 1 | 1976 | 75 | 0.000 |
Why?
|
Perfusion | 1 | 1981 | 1373 | 0.000 |
Why?
|
Vestibulocochlear Nerve | 1 | 1976 | 115 | 0.000 |
Why?
|
Algorithms | 1 | 1996 | 14032 | 0.000 |
Why?
|
Spine | 1 | 1982 | 1118 | 0.000 |
Why?
|
Ammonia | 1 | 1976 | 237 | 0.000 |
Why?
|
Internship and Residency | 1 | 1995 | 5882 | 0.000 |
Why?
|
Peripheral Nervous System Neoplasms | 1 | 1976 | 133 | 0.000 |
Why?
|
United States | 1 | 2003 | 72335 | 0.000 |
Why?
|
Cineradiography | 1 | 1973 | 22 | 0.000 |
Why?
|
Infant, Newborn | 1 | 1994 | 26198 | 0.000 |
Why?
|
Embolization, Therapeutic | 1 | 1982 | 1418 | 0.000 |
Why?
|
Astrocytoma | 1 | 1976 | 775 | 0.000 |
Why?
|
Neurilemmoma | 1 | 1976 | 526 | 0.000 |
Why?
|
Pain | 1 | 1984 | 5073 | 0.000 |
Why?
|
Meningioma | 1 | 1976 | 1218 | 0.000 |
Why?
|
Mitral Valve | 1 | 1973 | 1465 | 0.000 |
Why?
|
Aortic Valve | 1 | 1973 | 1955 | 0.000 |
Why?
|
Glioma | 1 | 1976 | 3455 | 0.000 |
Why?
|
Adenocarcinoma | 1 | 1976 | 6346 | 0.000 |
Why?
|